• Should Your Patient Be Tested
• Your Newly Diagnosed Patient
• Managing Your AAT Deficient Patient

Alpha1Health.com Survey

Take our survey to help us best meet the needs of the Alpha-1 community.

 

Choose a therapy that offers you the support you need.

 

ARALAST AATmosphere is a comprehensive support program for Alphas and their families.

One phone call puts your patient in touch with a team of healthcare and benefits specialists who can help with:

• Finding the right Home Care company
• Identifying the best fit for insurance needs
• Understanding the importance of augmentation therapy
• Learning about the infusion process
• Considering family testing

Aralast AATmosphere also puts newly diagnosed patients in touch with a team of trained advocates, all people living with AAT deficiency.

Learn about all the ways Aralast AATmosphere can help your patients and be a resource for you and your staff.

Call 1-866-ARALAST (1-866-272-5278) 8:30am-5:30pm Eastern Time or visit AATmosphere.com.

Read the Baxter News Release.

ARALAST [Alpha₁-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A₁-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A₁-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information